Category Archives: Cancer and neoplasms
Cancer and neoplasms
The efficacy and safety of multi-loop traction device for gastric endoscopic submucosal dissection: a single center prospective pilot study
Nov
Abstract Although gastric endoscopic submucosal dissection (ESD) is widely used, the degree of difficulty varies greatly depending on the lesion. Since the multi-loop traction device (MLTD) has been suggested to shorten the procedure time in colorectal ESD, we examined the efficacy and safety of using the MLTD in gastric ESD. Thirty patients with gastric neoplasms […]
Nov
Epworth HealthCare is creating a national register of pre-cancerous pancreatic cysts in the hope improving early detection of pancreatic cancer. Each year, 4,200 Australians are diagnosed with pancreatic cancer. The aggressive nature of the disease and late diagnosis means it has become the third leading cause of cancer-related deaths in Australia. Pancreatic cancer is tipped […]
Cancer and neoplasms
Regulatory Decisions and Research Boost Management Strategies for Hematologic Malignancies
Nov
Andrew Kuykendall, MD Newly approved JAK inhibitors are paving the way for future developments in the treatment of patients with myelofibrosis, according to Andrew Kuykendall, MD, who added that methods such as combination therapies with ruxolitinib (Jakafi) may further broaden the armamentarium. “The question is: How can we build upon the successes we’ve had and […]
Nov
News SPONSORED: The disease is more prevalent than ovarian and brain cancer, but many medical professionals still don’t know the symptoms. More than 50% of patients with neuroendocrine cancer experience symptoms for over five years and visit 4–6 healthcare professionals prior to obtaining a correct diagnosis. In 2021 neuroendocrine cancer became the seventh most pervasive […]
CAMBRIDGE, Mass. & CASTRES, France–(BUSINESS WIRE)– Foundation Medicine, Inc., and Pierre Fabre Laboratories today announced a collaboration to develop Foundation Medicine’s high-quality genomic tests, FoundationOne®CDx and FoundationOne®Liquid CDx, as companion diagnostics for new targeted therapies to treat patients with non-small cell lung cancer (NSCLC). The companies will work collaboratively to seek the regulatory approval for […]
Cancer and neoplasms
Histopathological features of glandular atrophy of the lamina propria of the gastric mucosa during its occurrence and development
Nov
Cho JH, Jeon SR, Jin SY, Park S. Standard vs magnifying narrow-band imaging endoscopy for diagnosis of Helicobacter pylori Infection and gastric precancerous conditions. World J Gastroenterol. 2021;27(18):2238–50. Article PubMed PubMed Central Google Scholar Ishikawa T, Matsumura T, Okimoto K, Nagashima A, Shiratori W, Kaneko T, Oura H, Tokunaga M, Akizue N, Ohta Y, Saito […]
New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) — The Global Endoscopic Submucosal Dissection Market Size is expected to reach USD 542.38 Million By 2032, at a CAGR of 5.4% during the forecast period 2022 to 2032. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/2492 Endoscopic Submucosal Dissection (ESD) is a minimally invasive procedure used for […]
Cancer and neoplasms
Exploring the Changing Diagnostic Criteria of Gorlin-Goltz Syndrome: A Case Report
Nov
ABSTRACT Gorlin-Goltz syndrome, also known as Gorlin syndrome, basal cell nevus syndrome, and nevoid basal cell carcinoma syndrome, is an autosomal dominant genetic disorder. Its hallmark is an early onset of basal cell carcinoma. Additionally, the syndrome is characterized by a spectrum of distinct clinical attributes encompassing oral, skeletal, ophthalmic, neurological, and developmental aberrations. This […]